標(biāo)題: Titlebook: Cellular Engineering and Cellular Therapies; Proceedings of the T C. Th. Smit Sibinga,L. F. M. H. Leij Conference proceedings 2003 Springer [打印本頁(yè)] 作者: 銀河 時(shí)間: 2025-3-21 19:06
書(shū)目名稱Cellular Engineering and Cellular Therapies影響因子(影響力)
書(shū)目名稱Cellular Engineering and Cellular Therapies影響因子(影響力)學(xué)科排名
書(shū)目名稱Cellular Engineering and Cellular Therapies網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱Cellular Engineering and Cellular Therapies網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱Cellular Engineering and Cellular Therapies被引頻次
書(shū)目名稱Cellular Engineering and Cellular Therapies被引頻次學(xué)科排名
書(shū)目名稱Cellular Engineering and Cellular Therapies年度引用
書(shū)目名稱Cellular Engineering and Cellular Therapies年度引用學(xué)科排名
書(shū)目名稱Cellular Engineering and Cellular Therapies讀者反饋
書(shū)目名稱Cellular Engineering and Cellular Therapies讀者反饋學(xué)科排名
作者: Clumsy 時(shí)間: 2025-3-21 23:25 作者: 捕鯨魚(yú)叉 時(shí)間: 2025-3-22 00:29 作者: 染色體 時(shí)間: 2025-3-22 06:52 作者: 沉思的魚(yú) 時(shí)間: 2025-3-22 11:37
Informationsmanagement und Controllingsecondary lymphoid organs, and other tissues in which T cell generation and proliferation take place. The composite impact of these factors leads to T cell immunodeficiency following allogeneic HSCT, which can contribute to unacceptably high rates of opportunistic infection and relapse. Improving th作者: 嘮叨 時(shí)間: 2025-3-22 13:03 作者: 嘮叨 時(shí)間: 2025-3-22 20:45
The New Regulatory Environment for Cellular Therapy Products: Challenges for Academic-Based Manufactd proposed regulations relevant to cellular therapy products. These new expectations have created substantial challenges for manufacturers, especially for academic-based laboratories that support early phase clinical trials not intended to result in a commercial product.作者: 宿醉 時(shí)間: 2025-3-23 01:01
Cell Manipulation and Engineering — State of the Art and Future Developmentsused for current good manufacturing practice (cGMP) be applied. With the advent of embryonic stem cell research and the literal explosion in new cellular tissues and components, the cGMP format became nearly unobtainable by most academic centers due to cost, physical requirements and regulatory/admi作者: magnanimity 時(shí)間: 2025-3-23 03:30
Factors Controlling Expansion and Maturation of Haematopoietic Progenitor Cellsn be used to generate large quantities of more mature progenitor cells, and a number of clinical studies have shown promising results [8–11]. During culture with cytokines, cells go through different stages of the cell cycle and the expression of cell surface adhesion molecules is altered; both fact作者: Fatten 時(shí)間: 2025-3-23 07:26
Reconstituting T Cell Immunity Following Hematopoietic Stem Cell Transplantationsecondary lymphoid organs, and other tissues in which T cell generation and proliferation take place. The composite impact of these factors leads to T cell immunodeficiency following allogeneic HSCT, which can contribute to unacceptably high rates of opportunistic infection and relapse. Improving th作者: explicit 時(shí)間: 2025-3-23 11:14
Conference proceedings 2003East. This year in particular the theme chosen some two years ago is extremely timely as it illustrates the activities and scientific interest of an integrated team which includes our regional Sanquin Blood Bank North-East and fits in the City initiatives within the concept of BioMedCity, Groningen.作者: GLIDE 時(shí)間: 2025-3-23 16:32 作者: 縮影 時(shí)間: 2025-3-23 21:36
https://doi.org/10.1007/978-3-322-99514-8n and application of appropriately differentiated embryonic or adult stem cells, still await the successful outcome of a lot of further experiments, others have been established and clinically applied already a long time ago. So, a lot of clinical experience has been obtained with both autologous an作者: atopic 時(shí)間: 2025-3-24 02:01 作者: Terminal 時(shí)間: 2025-3-24 02:53
Organisation und organisationaler Wandel is referred to as “stem cells”. This flurry of reports and the potential clinical utility of stem cells for a variety of human diseases merits a thorough analysis of biological concepts that are believed to rule stem cell functioning. To discuss some of the recent findings properly, it may be appro作者: foppish 時(shí)間: 2025-3-24 06:32
Organisation und organisationaler Wandelossibility to repopulate a damaged liver with normal liver cells. After injection into the portal vein, hepatocytes become correctly integrated into liver cell plates and are able to divide and perform a number of functions. Interestingly, transplanted hepatocytes become polarized and are able to se作者: chalice 時(shí)間: 2025-3-24 12:28
https://doi.org/10.1007/978-3-322-99570-4ts for a variety of malignant and non-malignant diseases. Many of these cellular therapies are already moving from the research bench to the clinic. The development, clinical evaluation, and dissemination of these therapies is largely dependent on the availability of reliable, clinically feasible me作者: inspiration 時(shí)間: 2025-3-24 18:06 作者: 止痛藥 時(shí)間: 2025-3-24 21:54
https://doi.org/10.1007/978-3-322-99598-8ne marrow, are now increasingly collected from blood for autologous and allogeneic transplantations. Umbilical cord blood, discarded until recently, has become a source of HSPC [1–4]. Recently, HSPC have been shown to have the potential to develop into cells of other organ systems [5–21]. In the lab作者: NIP 時(shí)間: 2025-3-24 23:29
Zusammenfassung der wichtigsten Ergebnisseug Administration (FDA) in guidance documents to encompass all materials of cellular or tissue origin used for therapeutic purposes [1]. This included autologous, allogeneic and xenogeneic materials. Initially, human bone marrow was one of the only products other than blood that was processed or man作者: Anhydrous 時(shí)間: 2025-3-25 06:28
Grundlagen der Referenzmodellierung,etting, adoptive transfer of Epstein Bar virus-specific T cells or infusion of donor lymphocytes, following relapse of chronic myelogenous leukemia, have proven their therapeutic potential. Theoretically, adoptive transfer therapy with highly purified and large quantities of specific CD8+ cytotoxic 作者: Intellectual 時(shí)間: 2025-3-25 10:31 作者: Extemporize 時(shí)間: 2025-3-25 15:29 作者: 綁架 時(shí)間: 2025-3-25 17:35
https://doi.org/10.1007/978-3-322-99957-3rational. The main objective for building this expensive facility was to enable translation of preclinical research into clinical protocols, with an emphasis on the preparation of genetically modified cellular products.作者: Chipmunk 時(shí)間: 2025-3-25 21:04
Informationsmanagement und Controllinge response [1]. It has been shown that DC pulsed with MHC class I peptides are potent inducers of a cytotoxic T lymphocyte (CTL) response . [2]. Furthermore, the presence of DC in tumor tissue has been correlated with a favorable clinical prognosis. Therefore DC are thought to play a pivotal role in作者: WATER 時(shí)間: 2025-3-26 01:04 作者: Cloudburst 時(shí)間: 2025-3-26 06:48
https://doi.org/10.1007/978-3-476-00192-4a wide variety of diseases. In addition, this knowledge may be used for the design of new therapeutics, based on the DNA sequence information. One of these approaches is gene therapy, where new genes are introduced in a patient to correct a specific disease. For many years, gene transfer techniques 作者: 尊嚴(yán) 時(shí)間: 2025-3-26 11:21 作者: encyclopedia 時(shí)間: 2025-3-26 14:22
978-1-4419-5250-9Springer Science+Business Media Dordrecht 2003作者: OASIS 時(shí)間: 2025-3-26 17:53
Gene Therapy 2002: A New Startpy in its very existence, it was hoped that easier navigation would lie ahead. Complications arising in the initial successful study of X-linked combined immune deficiency negate this hope. In this review we will produce some evidence for a promise of chances of success on a clinical level in the foreseeable future.作者: 共和國(guó) 時(shí)間: 2025-3-27 00:38 作者: 大笑 時(shí)間: 2025-3-27 03:22
,Ans?tze zur Komplexit?tshandhabung,py in its very existence, it was hoped that easier navigation would lie ahead. Complications arising in the initial successful study of X-linked combined immune deficiency negate this hope. In this review we will produce some evidence for a promise of chances of success on a clinical level in the foreseeable future.作者: Indent 時(shí)間: 2025-3-27 05:40
https://doi.org/10.1007/978-3-322-99957-3rational. The main objective for building this expensive facility was to enable translation of preclinical research into clinical protocols, with an emphasis on the preparation of genetically modified cellular products.作者: ALT 時(shí)間: 2025-3-27 12:23 作者: 竊喜 時(shí)間: 2025-3-27 17:09 作者: Halfhearted 時(shí)間: 2025-3-27 19:43 作者: 背信 時(shí)間: 2025-3-28 01:35 作者: Aesthete 時(shí)間: 2025-3-28 03:07 作者: 魅力 時(shí)間: 2025-3-28 07:46 作者: murmur 時(shí)間: 2025-3-28 13:31
Biological Modification of Lymphocytes in Auto- and Allo-Immune Diseases1 30 years, several peptides and proteins have been developed and have shown efficacy in treating both autoimmune and alloimmune disorders. The breadth of research into protein therapeutics has become huge and it is beyond the scope of this paper to fully analyze the literature. Thus, we will briefly作者: jovial 時(shí)間: 2025-3-28 16:29
Cell Harvest and Purification Technology — State of the Art and Future Developmentne marrow, are now increasingly collected from blood for autologous and allogeneic transplantations. Umbilical cord blood, discarded until recently, has become a source of HSPC [1–4]. Recently, HSPC have been shown to have the potential to develop into cells of other organ systems [5–21]. In the lab作者: DENT 時(shí)間: 2025-3-28 19:31 作者: 打擊 時(shí)間: 2025-3-29 00:43 作者: 切割 時(shí)間: 2025-3-29 06:47 作者: Metamorphosis 時(shí)間: 2025-3-29 11:16 作者: CON 時(shí)間: 2025-3-29 13:55 作者: 混合 時(shí)間: 2025-3-29 17:55
State of the Art in Dendritic Cell Vaccinatione response [1]. It has been shown that DC pulsed with MHC class I peptides are potent inducers of a cytotoxic T lymphocyte (CTL) response . [2]. Furthermore, the presence of DC in tumor tissue has been correlated with a favorable clinical prognosis. Therefore DC are thought to play a pivotal role in作者: Affectation 時(shí)間: 2025-3-29 23:28 作者: RACE 時(shí)間: 2025-3-30 02:10
State of the Art in Gene Therapya wide variety of diseases. In addition, this knowledge may be used for the design of new therapeutics, based on the DNA sequence information. One of these approaches is gene therapy, where new genes are introduced in a patient to correct a specific disease. For many years, gene transfer techniques 作者: 身心疲憊 時(shí)間: 2025-3-30 04:05 作者: 山間窄路 時(shí)間: 2025-3-30 12:03 作者: ventilate 時(shí)間: 2025-3-30 15:35 作者: Legend 時(shí)間: 2025-3-30 19:00
Organisation und organisationaler Wandellf [1]. This latter process, generally referred to as self-renewal, ensures that the stem cell population itself is never exhausted. Stem cells are typically divided in two main classes, embryonic stem cells and adult, or tissue-specific stem cells.作者: 枯燥 時(shí)間: 2025-3-31 00:02
Grundlagen der Referenzmodellierung,on); 3) The emergence of new escape variants that have lost the specific target antigens for these CTL; 4) The sophisticated and labor intensive infrastructure required, making this therapy extremely costly.作者: Cerumen 時(shí)間: 2025-3-31 03:49 作者: 彎曲道理 時(shí)間: 2025-3-31 06:20 作者: CLASH 時(shí)間: 2025-3-31 09:54
Cellular Immunotherapy — Towards Direct DC Activation for Licence to Killon); 3) The emergence of new escape variants that have lost the specific target antigens for these CTL; 4) The sophisticated and labor intensive infrastructure required, making this therapy extremely costly.
